Side Effects of the COVID-19 Vaccination among the Personnel of Negah Eye Hospital, Tehran, Iran
Journal of Ophthalmic and Optometric Sciences,
Vol. 7 No. 2 (2023),
2 Farvardin 2023
,
Page 25-34
https://doi.org/10.22037/joos.v7i2.45977
Abstract
Purpose: To investigate the complications of coronavirus vaccination among the personnel of Negah Eye Hospital, Tehran, Iran.
Patients and Methods: In this questionnaire-based survey we collected demographic characteristics as well as local and general vaccine complications among the personnel of Negah Eye Hospital, Tehran, Iran, including gastrointestinal, cardiac, pulmonary and ocular complications between June and August 2021.
Results: In this study, all personnel (n = 259) were evaluated. The mean age of participants was 42.58 ± 11.98 years. It was observed that 70.3 %, 24.7 %, and 5.0 % were vaccinated with AstraZeneca, Sputnik, and Baharat vaccines, respectively. Cases who were vaccinated with the first dose of AstraZeneca showed higher rate of fever (P < 0.001), chills (P < 0.001), muscle pain (P = 0.001), joint pain (P = 0.004), confusion (P = 0.002), drowsiness (P < 0.001), nausea (P = 0.014), and injection site pain (P = 0.005) compared to other types of vaccination. Post-injection complications mostly declined after the second dose. The most frequent complications secondary to vaccination were observed among younger and female participants (P < 0.05).
Conclusion: Complications were significantly higher after the first dose of AstraZeneca compared to Sputnik, and Bharat vaccines. Vaccine complications were higher after the first dose which remarkably decreased after the second dose of vaccination. Younger and female cases were in more risk of complication compared to older and male patients.
- Complications
- COVID-19
- Vaccination
- Iran
How to Cite
References
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199-207.
Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71-6.
Peyronnet V, Sibiude J, Huissoud C, Lescure FX, Lucet JC, Mandelbrot L, et al. Infection par le SARS-CoV-2 chez les femmes enceintes. Actualisation de l’état des connaissances et de la proposition de prise en charge. CNGOF [Infection with SARS-CoV-2 in pregnancy. Update of Information and proposed care. CNGOF]. Gynecol Obstet Fertil Senol. 2020;48(12):858-70. (Article in French)
Rajavi Z, Safi S, Mohammadzadeh M. Guidance for Ophthalmologists and Ophthalmology Centers during the COVID-19 Pandemic. J Ophthalmic Vis Res. 2020;15(3):438-41.
Calina D, Hartung T, Mardare I, Mitroi M, Poulas K, Tsatsakis A, Rogoveanu I, Docea AO. COVID-19 pandemic and alcohol consumption: Impacts and interconnections. Toxicol Rep. 2021;8:529-35.
Calina D, Sarkar C, Arsene AL, Salehi B, Docea AO, Mondal M, et al. Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development. Immunol Res. 2020;68(6):315-24.
Tsatsakis A, Calina D, Falzone L, Petrakis D, Mitrut R, Siokas V, et al. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol. 2020;146:111769.
Baraniuk C. What do we know about China's covid-19 vaccines? BMJ. 2021;373:n912.
Kumar VM, Pandi-Perumal SR, Trakht I, Thyagarajan SP. Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases. NPJ Vaccines. 2021;6(1):60.
Riad A, Pokorná A, Attia S, Klugarová J, Koščík M, Klugar M. Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic. J Clin Med. 2021;10(7):1428.
Vogel G, Kupferschmidt K. Side effect worry grows for AstraZeneca vaccine. Science. 2021;372(6537):14-5.
Boivin Z, Martin J. Untimely Myocardial Infarction or COVID-19 Vaccine Side Effect. Cureus. 2021;13(3):e13651.
Ledford H. COVID vaccines and blood clots: five key questions. Nature. 2021;592(7855):495-96.
Mathioudakis AG, Ghrew M, Ustianowski A, Ahmad S, Borrow R, Papavasileiou LP, et al. Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient Survey. Life (Basel). 2021;11(3):249.
Klugar M, Riad A, Mekhemar M, Conrad J, Buchbender M, Howaldt HP, Attia S. Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers. Biology (Basel). 2021;10(8):752.
Andrzejczak-Grządko S, Czudy Z, Donderska M. Side effects after COVID-19 vaccinations among residents of Poland. Eur Rev Med Pharmacol Sci. 2021;25(12):4418-21.
- Abstract Viewed: 108 times
- pdf Downloaded: 117 times
